Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.8.0.1
Notes Payable (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 10 Months Ended
Mar. 21, 2017
Mar. 13, 2017
Feb. 02, 2017
Nov. 03, 2016
Sep. 15, 2016
Mar. 31, 2016
Jun. 29, 2015
Feb. 02, 2015
Mar. 31, 2017
Sep. 30, 2017
Nov. 11, 2017
Jun. 30, 2017
May 31, 2017
Mar. 15, 2017
Mar. 07, 2017
Dec. 31, 2016
Feb. 03, 2015
Consideration received           $ 5,000,000                      
Estimated value of accounts receivable           $ 8,700,000                      
Adjustment value of debt                   $ 0           $ 1,500,000  
Investment percentage                   20.00%              
Debt term           6 months                      
Repayment of debt           $ 500,000                      
Debt instrument description           All payments recovered from the accounts receivable up to $5.25 million, if paid in full within six months, or $5.5 million, if not paid in full within six months, and (iii) 20% of all payments of the accounts receivable in excess of amounts received in (i) and (ii). On March 31, 2017, to the extent that the counterparty has not been paid $6.0 million, the Company was required to pay the difference, plus 30% interest per annum on the total balance. To date, the Company has not recovered any payments against the accounts receivable.                      
Accrued expenses                   $ 1,900,000              
Due to related party                   $ 6,900,000              
Debt instrument periodic payment       $ 400,000                          
Debt instrument maturity date                   Aug. 31, 2017              
Warrant to purchase common stock                           2,056      
Stock options exercise price per share                                
Loan outstanding                              
Accrued interest                   200,000              
Alcimede LLC [Member]                                  
Debt instrument maturity date               Feb. 02, 2016                  
Due from related party                                 $ 3,000,000
Debt instrument interest rate                                 6.00%
Debt instrument extended due date               Aug. 02, 2017                  
Share based payment of exercised options granted             66,667                    
Stock options exercise price per share             $ 37.50                    
Loan outstanding             $ 2,500,000                    
Repayment of common stock             $ 300,000                    
Mr Lagan [Member]                                  
Repayment of debt                 $ 50,000 100,000              
Debt instrument extended due date                 Feb. 02, 2018                
Stockholder [Member]                                  
Repayment of debt                     $ 50,000            
Due to related party                   $ 75,000              
Mr Diamantis [Member]                                  
Due to related party                       $ 3,600,000          
Debt instrument face amount                             $ 3,800,000    
Warrant to purchase common stock                             27,667    
Warrant exercise per share                             $ 15.00    
Debt instrument interest rate                       10.00% 10.00%        
TCA Debenture [Member]                                  
Repayment of debt $ 750,000                                
Accrued and unpaid interest 100,000   $ 400,000                            
Debt instrument fee $ 150,000                                
Debt instrument maturity date Jun. 27, 2017                                
TCA Debenture [Member] | April 2017 Through September 2017 [Member]                                  
Debt instrument periodic payment $ 2,600,000                                
September 2016 Notes [Member]                                  
Debt instrument maturity date         Mar. 15, 2017                        
Debt instrument conversion price         $ 112.50                        
Warrant to purchase common stock         4,444                        
Warrant exercise per share         $ 180.00                        
Warrant exchanged shares of common stock   26,667                              
September 2016 Notes [Member] | Two Investor [Member]                                  
Debt instrument face amount         $ 400,000